Strides Shasun stock drops by over 4% on US FDA observations
DSIJ Intelligence / 29 May 2017
The stock of pahrmaceutical company Strides Shasun dipped by over 4 per cent in intra-day trade on Monday after the US FDA issued observations on its Bangalore plant.
The stock of pharmaceutical company Strides Shasun dipped by over 4 per cent in intra-day trade on Monday after the US FDA issued observations on its Bangalore plant.
After the inspection by the US FDA, the company has been issued a Form 483, along with three observations. Observations under Form 483 are issued by the US FDA when investigators observe any practice that in their judgement may constitute violation of Foods Drugs and Cosmetics (FD&C) Act and other related acts.
Strides Shasun opened at Rs 894 on Monday (May 29) and closed at Rs 884, down by 3.68 per cent.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.